SCO-301 analogs (Scandion Oncology/University of Copenhagen)
N/A
Report date: 2025/03/20 15:21:29
NME
Base Information
Drug NameSCO-301 analogs (Scandion Oncology/University of Copenhagen)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScandion Oncology As
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of CopenhagenScandion Oncology As
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A